Septic Arthritis Market 2021 – Leading Manufactures, Regions, Drivers, Analysis and Forecasts Till 2027

Septic Arthritis Market Information: By Diagnosis (Joint Fluid Analysis, Blood Tests, Imaging), Treatment (Antibiotics, Surgery), Indication (Arthritis, Diabetes,), End User (Orthopedic Hospitals, Clinics, Diagnostic Centers) – Global Forecast till 2027

Market Highlights

Septic arthritis is inflammation of joints caused by the bacterial infection. Staphylococcal and Streptococcal bacteria are the most common bacteria that enter the wound and travel into the blood stream to the affect joints leading to inflammation. Septic arthritis causes severe pain, swelling, redness and heat in affected joints. The treatment available for septic arthritis involves the use of antibiotics and surgical procedure such as arthroscopy.

Rising prevalence of chronic diseases such as rheumatoid arthritis, diabetes and other diseases, extensive demand for the treatment of septic arthritis and increasing number of orthopedic or joint replacement surgeries stimulate the growth of the market.

Get Sample Report at

The global Septic Arthritis Treatment Market growth is expected to grow at a CAGR of 7.5% during the forecast period.

Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Septic arthritis market research report–Global forecast till 2023.”

Major Players in Septic Arthritis Market:

Some of the key players in the global market are Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson (U.S.), Pfizer (U.S.).


The global septic arthritis market is segmented on the basis of diagnosis, treatment, indication, and end user.

On the basis of diagnosis, market is segmented into joint fluid analysis, blood tests, imaging and others. Imaging is further segmented into X-ray, ultrasonography, MRI and CT scan.

On the basis of treatment, the market is segmented into antibiotics, aspiration of the joint, surgery and others. Surgery is further segmented into arthrotomy and arthroscopy.

On the basis of indication, the market is segmented into arthritis, hip or knee prosthesis, poor immune function, joint surgery and others.

On the basis of end user, the market is segmented into orthopedic hospitals, clinics, pharmaceutical companies and others.

Regional Analysis

America is the largest market for septic arthritis owing to rising prevalence of obesity and septic arthritis in the U.S., especially among the pediatric population.  According to the National Institute for Diabetes and Digestive and Kidney Disease, in the U.S. more than 1 in 3 adults were overweight during 2013-2014. According to the Center for Disease Control and Prevention, from 2013- 2015, an estimated 54.4 million U.S. adults annually were diagnosed with rheumatoid arthritis, gout, lupus, or fibromyalgia. It also stated that the risk of arthritis increases with age and disease is common in women than in men.

Europe is the second largest market for septic arthritis owing to the rising prevalence of rheumatoid arthritis and obesity in European countries and availability of funds for research and development activities. According to the World Health Organization (WHO), in European Union countries, nearly 30-70% of the population is obese.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by rising geriatric population, and high prevalence of chronic disease such as diabetes, and obesity. Diabetes is one of the major problems in Asia Pacific further creating opportunities for the market growth. According to the International Diabetes Foundation, 98.4 million and 65.1 million diabetic patients live in China and India respectively.

The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases.

Access Report Details @

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]